These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18607526)

  • 1. Blocking kinetics of memantine on NR1a/2A receptors recorded in inside-out and outside-out patches from Xenopus oocytes.
    Parsons CG; Gilling KE; Jatzke C
    J Neural Transm (Vienna); 2008 Oct; 115(10):1367-73. PubMed ID: 18607526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
    Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL
    Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization.
    Parsons CG; Danysz W; Bartmann A; Spielmanns P; Frankiewicz T; Hesselink M; Eilbacher B; Quack G
    Neuropharmacology; 1999 Jan; 38(1):85-108. PubMed ID: 10193901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memantine does not show intracellular block of the NMDA receptor channel.
    Parsons CG; Gilling KE; Jatzke C
    Eur J Pharmacol; 2008 Jun; 587(1-3):99-103. PubMed ID: 18456253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
    Gilling KE; Jatzke C; Hechenberger M; Parsons CG
    Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist concentration dependency of blocking kinetics but not equilibrium block of N-methyl-D-aspartate receptors by memantine.
    Gilling KE; Jatzke C; Parsons CG
    Neuropharmacology; 2007 Sep; 53(3):415-20. PubMed ID: 17632186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices.
    Frankiewicz T; Potier B; Bashir ZI; Collingridge GL; Parsons CG
    Br J Pharmacol; 1996 Feb; 117(4):689-97. PubMed ID: 8646415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.
    Parsons CG; Quack G; Bresink I; Baran L; Przegalinski E; Kostowski W; Krzascik P; Hartmann S; Danysz W
    Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patch clamp combined with voltage/concentration clamp to determine the kinetics and voltage dependency of N-methyl-D-aspartate (NMDA) receptor open channel blockers.
    Parsons CG; Gilling KE
    Methods Mol Biol; 2014; 1183():43-63. PubMed ID: 25023301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potencies and unblocking kinetic properties of antagonists at recombinant human NMDA receptors in a Xenopus oocytes model.
    Heusler P; Tourette A; Cussac D
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):509-16. PubMed ID: 25604077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors.
    Wyllie DJ; Béhé P; Colquhoun D
    J Physiol; 1998 Jul; 510 ( Pt 1)(Pt 1):1-18. PubMed ID: 9625862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.
    Avenet P; Léonardon J; Besnard F; Graham D; Depoortere H; Scatton B
    Neurosci Lett; 1997 Feb; 223(2):133-6. PubMed ID: 9089691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human NMDA receptor GluN2A
    Marwick KFM; Skehel PA; Hardingham GE; Wyllie DJA
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00495. PubMed ID: 31249692
    [No Abstract]   [Full Text] [Related]  

  • 14. Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes.
    Wrighton DC; Baker EJ; Chen PE; Wyllie DJ
    J Physiol; 2008 Jan; 586(1):211-25. PubMed ID: 17962329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-channel properties of native and cloned rat vanilloid receptors.
    Premkumar LS; Agarwal S; Steffen D
    J Physiol; 2002 Nov; 545(1):107-17. PubMed ID: 12433953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism.
    Chen HS; Lipton SA
    J Physiol; 1997 Feb; 499 ( Pt 1)(Pt 1):27-46. PubMed ID: 9061638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subunit-specific effects of poricoic acid A on NMDA receptors.
    Lee J; Kim C; Yeom HD; Nguyen KVA; Eom S; Lee S; Jung JH; Lee JH; Kim SH; Kim IK; Lee JH
    Pharmacol Rep; 2020 Apr; 72(2):472-480. PubMed ID: 32048268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of a threonine residue in the S2 ligand binding domain in determining agonist potency and deactivation rate of recombinant NR1a/NR2D NMDA receptors.
    Chen PE; Johnston AR; Mok MH; Schoepfer R; Wyllie DJ
    J Physiol; 2004 Jul; 558(Pt 1):45-58. PubMed ID: 15107472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors.
    Kloda A; Clements JD; Lewis RJ; Adams DJ
    Mol Pharmacol; 2004 Jun; 65(6):1386-96. PubMed ID: 15155832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine as an example of a fast, voltage-dependent, open channel N-methyl-D-aspartate receptor blocker.
    Parsons CG; Gilling K
    Methods Mol Biol; 2007; 403():15-36. PubMed ID: 18827985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.